- Home
- SGMT vs STEM Comparison
SGMT vs STEM Comparison
Compare SGMT & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | STEM |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.6M | 137.9M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SGMT | STEM |
|---|---|---|
| Price | $5.77 | $10.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $27.00 | $14.60 |
| AVG Volume (30 Days) | ★ 566.6K | 162.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.49 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,000,000.00 | ★ $144,584,000.00 |
| Revenue This Year | N/A | $5.48 |
| Revenue Next Year | N/A | $12.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.73 | $0.29 |
| 52 Week High | $11.41 | $32.23 |
Technical Indicators
Market Signals| Indicator | SGMT | STEM |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 35.81 |
| Support Level | $5.60 | $0.38 |
| Resistance Level | $6.72 | $12.05 |
| Average True Range (ATR) | 0.33 | 0.76 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 62.78 | 42.30 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.